Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials. Fu H, Hou W, Zhang Y, Hu X, et al. PLoS One 2022;17:e0269111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fu H, Hou W, Zhang Y, Hu X, et al. Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials. PLoS One 2022;17:e0269111.
PMID: 35617324